Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Cash from Investing Activities: 2022-2024

Historic Cash from Investing Activities for Sagimet Biosciences (SGMT) over the last 3 years, with Dec 2024 value amounting to -$61.7 million.

  • Sagimet Biosciences' Cash from Investing Activities was N/A to $624,000 in Q3 2024 from the same period last year, while for Sep 2024 it was -$91.2 million, marking a year-over-year change of. This contributed to the annual value of -$61.7 million for FY2024, which is 590.33% down from last year.
  • Per Sagimet Biosciences' latest filing, its Cash from Investing Activities stood at -$61.7 million for FY2024, which was down 590.33% from $12.6 million recorded in FY2023.
  • In the past 5 years, Sagimet Biosciences' Cash from Investing Activities ranged from a high of $12.6 million in FY2023 and a low of -$61.7 million during FY2024.
  • In the last 3 years, Sagimet Biosciences' Cash from Investing Activities had a median value of -$32.0 million in 2022 and averaged -$27.0 million.
  • As far as peak fluctuations go, Sagimet Biosciences' Cash from Investing Activities soared by 139.30% in 2023, and later tumbled by 590.33% in 2024.
  • Sagimet Biosciences' Cash from Investing Activities (Yearly) stood at -$32.0 million in 2022, then surged by 139.30% to $12.6 million in 2023, then plummeted by 590.33% to -$61.7 million in 2024.